Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Underwriting Agreement
- 3.1 Certificate of Amendment to the Certificate of Incorporation of Elevai Labs, Inc., Fka Reactive Medical Labs Inc
- 3.2 Amendment to Second Amended and Restated Certificate of Incorporation of Elevai Labs, Inc
- 3.3 Form of Third Amended and Restated Certificate of Incorporation of Elevai Labs, Inc., to Be Effective Upon the Closing of This Offering
- 3.4 By-laws
- 3.5 Form of Amended and Restated Bylaws of Elevai Labs, Inc., to Be Effective Upon the Closing of This Offering
- 4.1 Form of Common Stock Share Certificate
- 5.1 Opinion of Ortoli Rosenstadt LLP Regarding the Validity of the Securities Being Registered
- 10.1 Stock Transfer Agreement, Dated June 4, 2021, Between BWL Investments LTD. and Reactive Medical Labs Inc
- 10.2 2020 Equity Incentive Plan, As Amended, and Forms of Award Agreements Thereunder
- 10.3 Form of Amended and Restated Consulting Agreement Between Elevai Labs, Inc. and Northstrive Companies Inc
- 10.4 Form of Advisory Agreement Between Elevai Labs, Inc. and Braeden Lichti
- 10.5 Form of Independent Director Offer Letter
- 10.6 Authorized Distributor Agreement, Dated August 30, 2022, Between Elevai Labs, Inc. and Refine USA, LLC
- 10.7 Authorized Distributor and Trademark License Agreement, Dated January 17, 2022, Between Elevai Labs, Inc. and Dermapenworld Pty LTD
- 14.1 Code of Ethics
- 21.1 List of Subsidiaries
- 23.2 Consent of TPS Thayer
- 99.1 Audit Committee Charter
- 99.2 Compensation Committee Charter
- 99.3 Nominating Committee Charter
- EX-FILING FEES Filing Fee Table
Associated filings
ELAB similar filings
Filing view
External links
Exhibit 21.1
Elevai Labs, Inc.
List of Subsidiaries
Name of Subsidiary | Jurisdiction of Incorporation or Organization | |
Elevai Research Inc. | Canada |